| 292 |
[2019 Apr;43(2)] Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
|
|
2019.04.18 |
3384 |
| 291 |
[2019 Apr;43(2)] Metabolic Consequences of Obstructive Sleep Apnea Especially Pertaining to Diabetes Mellitus and Insulin Sensitivity
|
|
2019.04.18 |
3128 |
| 290 |
[2019 Apr;43(2)] Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
|
|
2019.04.18 |
3085 |
| 289 |
[2019 Feb;43(1)] Higher High Density Lipoprotein 2 (HDL2) to Total HDL Cholesterol Ratio Is Associated with a Lower Risk for Incident Hypertension
|
|
2019.03.06 |
1350 |
| 288 |
[2019 Feb;43(1)] Proportion and Characteristics of the Subjects with Low Muscle Mass and Abdominal Obesity among the Newly Diagnosed and Drug-Naïve Type 2 Diabetes Mellitus Patients
|
|
2019.03.06 |
1262 |
| 287 |
[2019 Feb;43(1)] Soluble Dipeptidyl Peptidase-4 Levels Are Associated with Decreased Renal Function in Patients with Type 2 Diabetes Mellitus
|
|
2019.03.06 |
1258 |
| 286 |
[2019 Feb;43(1)] Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data
|
|
2019.03.06 |
1301 |
| 285 |
[2019 Feb;43(1)] High Proportion of Adult Cases and Prevalence of Metabolic Syndrome in Type 1 Diabetes Mellitus Population in Korea: A Nationwide Study
|
|
2019.03.06 |
1172 |
| 284 |
[2019 Feb;43(1)] Association of Bisphenol A and Its Substitutes, Bisphenol F and Bisphenol S, with Obesity in United States Children and Adolescents
|
|
2019.03.06 |
1329 |
| 283 |
[2019 Feb;43(1)] Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study
|
|
2019.03.06 |
1218 |
| 282 |
[2019 Feb;43(1)] Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
|
|
2019.03.06 |
1208 |
| 281 |
[2019 Feb;43(1)] Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet
|
|
2019.03.06 |
1194 |
| 280 |
[2018 Dec;42(6)] The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran
|
|
2019.03.06 |
1228 |
| 279 |
[2018 Dec;42(6)] Utility of Serum Albumin for Predicting Incident Metabolic Syndrome According to Hyperuricemia
|
|
2019.03.06 |
1229 |
| 278 |
[2018 Dec;42(6)] Patterns of Nerve Conduction Abnormalities in Patients with Type 2 Diabetes Mellitus According to the Clinical Phenotype Determined by the Current Perception Threshold
|
|
2019.03.06 |
1467 |
| 277 |
[2018 Dec;42(6)] Association between Serum Cystatin C and Vascular Complications in Type 2 Diabetes Mellitus without Nephropathy
|
|
2019.03.06 |
1088 |
| 276 |
[2018 Dec;42(6)] Cardiovascular Autonomic Neuropathy Predicts Higher HbA1c Variability in Subjects with Type 2 Diabetes Mellitus
|
|
2019.03.06 |
1288 |
| 275 |
[2018 Dec;42(6)] Association of Thigh Muscle Mass with Insulin Resistance and Incident Type 2 Diabetes Mellitus in Japanese Americans
|
|
2019.03.06 |
1222 |
| 274 |
[2018 Dec;42(6)] Frequency of Self-Monitoring of Blood Glucose during the School Day Is Associated with the Optimal Glycemic Control among Korean Adolescents with Type 1 Diabetes
|
|
2019.03.06 |
1268 |
| 273 |
[2018 Dec;42(6)] A Journey to Understand Glucose Homeostasis: Starting from Rat Glucose Transporter Type 2 Promoter Cloning to Hyperglycemia
|
|
2019.03.06 |
1209 |
